TrialThe British journal of surgery2021

Early response to upfront neoadjuvant chemotherapy (CAPOX) alone in low- and intermediate-risk rectal cancer: a single-arm phase II trial.

Xiangbing Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.